loadpatents
name:-0.13418912887573
name:-0.096168041229248
name:-0.0088438987731934
Rossi; Edmund A. Patent Filings

Rossi; Edmund A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rossi; Edmund A..The latest application filed is for "combination therapy for inducing immune response to disease".

Company Profile
7.89.103
  • Rossi; Edmund A. - Woodland Park NJ
  • ROSSI; Edmund A. - Nutley NJ
  • Rossi; Edmund A. - Morris Plains NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant 10,662,252 - Chang , et al.
2020-05-26
T-cell redirecting bispecific antibodies for treatment of disease
Grant 10,308,688 - Chang , et al.
2019-06-04
Combination Therapy For Inducing Immune Response To Disease
App 20190142939 - Chang; Chien-Hsing ;   et al.
2019-05-16
Combination therapy for inducing immune response to disease
Grant 10,245,321 - Chang , et al.
2019-04-02
T-cell redirecting bispecific antibodies for treatment of disease
Grant 10,239,938 - Chang , et al.
2019-03-26
T-cell redirecting bispecific antibodies for treatment of disease
Grant 10,183,992 - Chang , et al. Ja
2019-01-22
Combination therapy with T-cell redirecting bispecific antibodies and checkpoint inhibitors
Grant 10,131,712 - Rossi , et al. November 20, 2
2018-11-20
Combination therapy for inducing immune response to disease
Grant 10,111,954 - Chang , et al. October 30, 2
2018-10-30
Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
Grant 9,963,507 - Chang , et al. May 8, 2
2018-05-08
Stable compositions of high-concentration allotype-selected antibodies for small-volume administration
Grant 9,963,516 - Zeng , et al. May 8, 2
2018-05-08
Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
App 20180118846 - Chang; Chien-Hsing ;   et al.
2018-05-03
Tetrameric cytokines with improved biological activity
Grant 9,931,413 - Chang , et al. April 3, 2
2018-04-03
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant 9,879,088 - Chang , et al. January 30, 2
2018-01-30
PEGylation by the dock and lock (DNL) technique
Grant 9,872,920 - Chang , et al. January 23, 2
2018-01-23
Fusion Proteins Containing Recombinant Cytotoxic Rnases
App 20170334996 - GOLDENBERG; David M. ;   et al.
2017-11-23
Combination Therapy For Inducing Immune Response To Disease
App 20170281767 - Chang; Chien-Hsing ;   et al.
2017-10-05
Combination Therapy With T-cell Redirecting Bispecific Antibodies And Checkpoint Inhibitors
App 20170275375 - Rossi; Edmund A. ;   et al.
2017-09-28
Stable Compositions of High-Concentration Allotype-Selected Antibodies for Small-Volume Administration
App 20170260287 - Zeng; Li ;   et al.
2017-09-14
T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
App 20170247417 - Chang; Chien-Hsing ;   et al.
2017-08-31
Fusion proteins containing recombinant cytotoxic RNAses
Grant 9,745,374 - Goldenberg , et al. August 29, 2
2017-08-29
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
Grant 9,737,617 - Chang , et al. August 22, 2
2017-08-22
Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
App 20170226219 - Chang; Chien-Hsing ;   et al.
2017-08-10
Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis
App 20170226205 - Chang; Chien-Hsing ;   et al.
2017-08-10
Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments
App 20170173167 - Goldenberg; David M. ;   et al.
2017-06-22
Combination therapy for inducing immune response to disease
Grant 9,682,143 - Chang , et al. June 20, 2
2017-06-20
Stable compositions of high-concentration allotype-selected antibodies for small-volume administration
Grant 9,683,050 - Zeng , et al. June 20, 2
2017-06-20
Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology
App 20170166651 - Chang; Chien-Hsing ;   et al.
2017-06-15
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant 9,670,286 - Chang , et al. June 6, 2
2017-06-06
Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
Grant 9,663,576 - Chang , et al. May 30, 2
2017-05-30
Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses
App 20170121692 - Chang; Chien-Hsing ;   et al.
2017-05-04
Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock
Grant 9,617,531 - Chang , et al. April 11, 2
2017-04-11
Tetrameric Cytokines with Improved Biological Activity
App 20170056516 - Chang; Chien-Hsing ;   et al.
2017-03-02
T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
App 20170022274 - Chang; Chien-Hsing ;   et al.
2017-01-26
Combination Therapy For Inducing Immune Response To Disease
App 20170021017 - Chang; Chien-Hsing ;   et al.
2017-01-26
Stably tethered structures of defined compositions with multiple functions or binding specificities
Grant 9,540,435 - Chang , et al. January 10, 2
2017-01-10
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
Grant 9,540,618 - Chang , et al. January 10, 2
2017-01-10
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
App 20160375108 - Chang; Chien-Hsing ;   et al.
2016-12-29
Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis
App 20160368986 - Chang; Chien-Hsing ;   et al.
2016-12-22
PEGylation by the Dock and Lock (DNL) Technique
App 20160361435 - Chang; Chien-Hsing ;   et al.
2016-12-15
Multimeric Complexes with Improved in Vivo Stability, Pharmacokinetics and Efficacy
App 20160340443 - Rossi; Edmund A. ;   et al.
2016-11-24
Tetrameric cytokines with improved biological activity
Grant 9,498,542 - Chang , et al. November 22, 2
2016-11-22
Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
Grant 9,481,878 - Chang , et al. November 1, 2
2016-11-01
Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
Grant 9,475,883 - Chang , et al. October 25, 2
2016-10-25
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
Grant 9,468,689 - Zeng , et al. October 18, 2
2016-10-18
PEGylation by the dock and lock (DNL) technique
Grant 9,457,100 - Chang , et al. October 4, 2
2016-10-04
Multimeric complexes with improved in vivo stability, pharmacokinetics and efficacy
Grant 9,446,123 - Rossi , et al. September 20, 2
2016-09-20
Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
App 20160264678 - Chang; Chien-Hsing ;   et al.
2016-09-15
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
App 20160257947 - Chang; Chien-Hsing ;   et al.
2016-09-08
Therapeutic Use Of Anti-cd22 Antibodies For Inducing Trogocytosis
App 20160251444 - Chang; Chien-Hsing ;   et al.
2016-09-01
Combination Therapy With Anti-CD74 and Anti-CD20 Antibodies Provides Enhanced Toxicity to B-Cell Diseases
App 20160243226 - Chang; Chien-Hsing ;   et al.
2016-08-25
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant 9,382,329 - Chang , et al. July 5, 2
2016-07-05
T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
App 20160176980 - Chang; Chien-Hsing ;   et al.
2016-06-23
T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
App 20160176968 - Chang; Chien-Hsing ;   et al.
2016-06-23
Combination therapy with anti-CD74 and anti-CD20 antibodies provides enhanced toxicity to B-cell diseases
Grant 9,359,443 - Chang , et al. June 7, 2
2016-06-07
T-cell redirecting bispecific antibodies for treatment of disease
Grant 9,315,567 - Chang , et al. April 19, 2
2016-04-19
Stable Compositions of High-Concentration Allotype-Selected Antibodies for Small-Volume Administration
App 20160032008 - Zeng; Li ;   et al.
2016-02-04
Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis
App 20160032003 - Chang; Chien-Hsing ;   et al.
2016-02-04
Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
App 20150374846 - Chang; Chien-Hsing ;   et al.
2015-12-31
Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
Grant 9,192,664 - Chang , et al. November 24, 2
2015-11-24
Stable compositions of high-concentration allotype-selected antibodies for small-volume administration
Grant 9,180,205 - Zeng , et al. November 10, 2
2015-11-10
Methods and compositions for generating bioactive assemblies of increased complexity and uses
Grant 9,169,470 - Chang , et al. October 27, 2
2015-10-27
Combination Therapy For Inducing Immune Response To Disease
App 20150231241 - Chang; Chien-Hsing ;   et al.
2015-08-20
Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments
App 20150224192 - Goldenberg; David M. ;   et al.
2015-08-13
Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
App 20150132217 - Chang; Chien-Hsing ;   et al.
2015-05-14
Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses
App 20150056680 - Chang; Chien-Hsing ;   et al.
2015-02-26
Stably Tethered Structures of Defined Compositions with Multiple Functions or Binding Specificities
App 20150050715 - Chang; Chien-Hsing ;   et al.
2015-02-19
Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
App 20150037283 - Chang; Chien-Hsing ;   et al.
2015-02-05
Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases
App 20150023870 - Chang; Chien-Hsing ;   et al.
2015-01-22
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
Grant 8,932,593 - Chang , et al. January 13, 2
2015-01-13
Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
App 20150010982 - Chang; Chien-Hsing ;   et al.
2015-01-08
Stably tethered structures of defined compositions with multiple functions or binding specificities
Grant 8,906,377 - Chang , et al. December 9, 2
2014-12-09
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
Grant 8,906,378 - Chang , et al. December 9, 2
2014-12-09
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,889,410 - Goldenberg , et al. November 18, 2
2014-11-18
Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
Grant 8,871,216 - Chang , et al. October 28, 2
2014-10-28
Methods and compositions for generating bioactive assemblies of increased complexity and uses
Grant 8,865,176 - Chang , et al. October 21, 2
2014-10-21
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20140308703 - Goldenberg; David M. ;   et al.
2014-10-16
Nucleic acids encoding polyvalent protein complexes
Grant 8,829,175 - Rossi , et al. September 9, 2
2014-09-09
Therapeutic Use Of Anti-cd22 Antibodies For Inducing Trogocytosis
App 20140212425 - Chang; Chien-Hsing ;   et al.
2014-07-31
Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration
App 20140193359 - Zeng; Li ;   et al.
2014-07-10
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,771,987 - Goldenberg , et al. July 8, 2
2014-07-08
Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration
App 20140178294 - Zeng; Li ;   et al.
2014-06-26
Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments
App 20140170065 - Goldenberg; David M. ;   et al.
2014-06-19
Tetrameric Cytokines with Improved Biological Activity
App 20140161766 - Chang; Chien-Hsing ;   et al.
2014-06-12
Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
Grant 8,697,080 - Goldenberg , et al. April 15, 2
2014-04-15
Combination Therapy For Inducing Immune Response To Disease
App 20140099254 - Chang; Chien-Hsing ;   et al.
2014-04-10
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
Grant 8,658,773 - Zeng , et al. February 25, 2
2014-02-25
T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
App 20140050660 - Chang; Chien-Hsing ;   et al.
2014-02-20
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20140038284 - Goldenberg; David M. ;   et al.
2014-02-06
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
App 20140038261 - Chang; Chien-Hsing ;   et al.
2014-02-06
Multimeric Complexes with Improved in Vivo Stability, Pharmacokinetics and Efficacy
App 20130323204 - Rossi; Edmund A. ;   et al.
2013-12-05
Tetrameric cytokines with improved biological activity
Grant 8,597,659 - Chang , et al. December 3, 2
2013-12-03
Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
App 20130295005 - Chang; Chien-Hsing ;   et al.
2013-11-07
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,569,054 - Goldenberg , et al. October 29, 2
2013-10-29
Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
Grant 8,551,480 - Chang , et al. October 8, 2
2013-10-08
Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
App 20130217091 - Chang; Chien-Hsing ;   et al.
2013-08-22
PEGylation by the Dock and Lock (DNL) Technique
App 20130177532 - Chang; Chien-Hsing ;   et al.
2013-07-11
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
Grant 8,475,794 - Chang , et al. July 2, 2
2013-07-02
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20130164783 - Goldenberg; David M. ;   et al.
2013-06-27
Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
App 20130164816 - Chang; Chien-Hsing ;   et al.
2013-06-27
Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis
App 20130142787 - Chang; Chien-Hsing ;   et al.
2013-06-06
Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in VIVO
Grant 8,435,540 - Chang , et al. May 7, 2
2013-05-07
Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology
App 20130109073 - Chang; Chien-Hsing ;   et al.
2013-05-02
Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases
App 20130078183 - Chang; Chien-Hsing ;   et al.
2013-03-28
Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments
App 20130071406 - Goldenberg; David M. ;   et al.
2013-03-21
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,372,603 - Goldenberg , et al. February 12, 2
2013-02-12
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
Grant 8,349,332 - Chang , et al. January 8, 2
2013-01-08
Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration
App 20120321553 - Zeng; Li ;   et al.
2012-12-20
Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
Grant 8,333,971 - Goldenberg , et al. December 18, 2
2012-12-18
Multivalent Immunoglobulin-Based Bioactive Assemblies
App 20120276608 - Chang; Chien-Hsing ;   et al.
2012-11-01
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
App 20120276100 - Chang; Chien-Hsing ;   et al.
2012-11-01
Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
Grant 8,282,934 - Chang , et al. October 9, 2
2012-10-09
PEGylation by the dock and lock (DNL) technique
Grant 8,277,817 - Chang , et al. October 2, 2
2012-10-02
Design and Construction of Novel Multivalent Antibodies
App 20120237442 - Rossi; Edmund A. ;   et al.
2012-09-20
Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
App 20120225032 - Chang; Chien-Hsing ;   et al.
2012-09-06
Methods and compositions for generating bioactive assemblies of increased complexity and uses
Grant 8,246,960 - Chang , et al. August 21, 2
2012-08-21
Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses
App 20120196346 - Chang; Chien-Hsing ;   et al.
2012-08-02
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20120196326 - Goldenberg; David M. ;   et al.
2012-08-02
Multivalent immunoglobulin-based bioactive assemblies
Grant 8,211,440 - Chang , et al. July 3, 2
2012-07-03
Fusion Proteins Containing Recombinant Cytotoxic Rnases
App 20120149085 - GOLDENBERG; David M. ;   et al.
2012-06-14
Fusion proteins containing recombinant cytotoxic RNAses
Grant 8,192,739 - Goldenberg , et al. June 5, 2
2012-06-05
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
Grant 8,163,291 - Chang , et al. April 24, 2
2012-04-24
Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
Grant 8,158,129 - Chang , et al. April 17, 2
2012-04-17
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20120088299 - Goldenberg; David M. ;   et al.
2012-04-12
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,153,433 - Goldenberg , et al. April 10, 2
2012-04-10
Tetrameric Cytokines with Improved Biological Activity
App 20120009149 - Chang; Chien-Hsing ;   et al.
2012-01-12
Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology
App 20110318306 - Chang; Chien-Hsing ;   et al.
2011-12-29
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,076,140 - Goldenberg , et al. December 13, 2
2011-12-13
Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
App 20110300066 - Chang; Chien-Hsing ;   et al.
2011-12-08
Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
App 20110300105 - Chang; Chien-Hsing ;   et al.
2011-12-08
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
App 20110274704 - Chang; Chien-Hsing ;   et al.
2011-11-10
Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases
App 20110256053 - Chang; Chien-Hsing ;   et al.
2011-10-20
Tetrameric cytokines with improved biological activity
Grant 8,034,352 - Chang , et al. October 11, 2
2011-10-11
PEGylation by the Dock and Lock (DNL) Technique
App 20110236352 - Chang; Chien-Hsing ;   et al.
2011-09-29
Methods for Protein Expression in Mammalian Cells in Serum-Free Medium
App 20110236404 - Goldenberg; David M. ;   et al.
2011-09-29
Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivo
Grant 8,003,111 - Chang , et al. August 23, 2
2011-08-23
Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
App 20110195020 - Chang; Chien-Hsing ;   et al.
2011-08-11
PEGylation by the dock and lock (DNL) technique
Grant 7,981,398 - Chang , et al. July 19, 2
2011-07-19
Stably Tethered Structures of Defined Compositions with Multiple Functions or Binding Specificities
App 20110143417 - Chang; Chien-Hsing ;   et al.
2011-06-16
Multivalent Immunoglobulin-Based Bioactive Assemblies
App 20110110851 - Chang; Chien-Hsing ;   et al.
2011-05-12
Methods and compositions for generating bioactive assemblies of increased complexity and uses
Grant 7,906,121 - Chang , et al. March 15, 2
2011-03-15
Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
Grant 7,906,118 - Chang , et al. March 15, 2
2011-03-15
Stably tethered structures of defined compositions with multiple functions or binding specificities
Grant 7,871,622 - Chang , et al. January 18, 2
2011-01-18
Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses
App 20110008251 - Chang; Chien-Hsing ;   et al.
2011-01-13
Multivalent immunoglobulin-based bioactive assemblies
Grant 7,858,070 - Chang , et al. December 28, 2
2010-12-28
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20100311162 - Goldenberg; David M. ;   et al.
2010-12-09
PEGylation by the Dock and Lock (DNL) Technique
App 20100261885 - Chang; Chien-Hsing ;   et al.
2010-10-14
Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
App 20100221210 - Chang; Chien-Hsing ;   et al.
2010-09-02
Mammalian cell lines for increasing longevity and protein yield from cell culture
Grant 7,785,880 - Goldenberg , et al. August 31, 2
2010-08-31
Tetrameric Cytokines with Improved Biological Activity
App 20100189689 - Chang; Chien-Hsing ;   et al.
2010-07-29
PEGylation by the dock and lock (DNL) technique
Grant 7,666,400 - Chang , et al. February 23, 2
2010-02-23
Multivalent Immunoglobulin-Based Bioactive Assemblies
App 20090269277 - Chang; Chien-Hsing ;   et al.
2009-10-29
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20090253179 - Goldenberg; David M. ;   et al.
2009-10-08
Fusion Proteins Containing Recombinant Cytotoxic Rnases
App 20090246214 - GOLDENBERG; David M. ;   et al.
2009-10-01
Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
App 20090202433 - Chang; Chien-Hsing ;   et al.
2009-08-13
Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology
App 20090202487 - Chang; Chien-Hsing ;   et al.
2009-08-13
Stably Tethered Structures of Defined Compositions with Multiple Functions or Binding Specificities
App 20090191225 - Chang; Chien-Hsing ;   et al.
2009-07-30
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
Grant 7,550,143 - Chang , et al. June 23, 2
2009-06-23
Fusion proteins containing recombinant cytotoxic RNAses
Grant 7,544,487 - Goldenberg , et al. June 9, 2
2009-06-09
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 7,537,930 - Goldenberg , et al. May 26, 2
2009-05-26
Methods and compositions for generating bioactive assemblies of increased complexity and uses
Grant 7,534,866 - Chang , et al. May 19, 2
2009-05-19
Methods and compositions for increasing longevity and protein yield from a cell culture
Grant 7,531,327 - Goldenberg , et al. May 12, 2
2009-05-12
Multivalent immunoglobulin-based bioactive assemblies
Grant 7,527,787 - Chang , et al. May 5, 2
2009-05-05
Stably tethered structures of defined compositions with multiple functions or binding specificities
Grant 7,521,056 - Chang , et al. April 21, 2
2009-04-21
PEGylation by the Dock and Lock (DNL) Technique
App 20090060862 - Chang; Chien-Hsing ;   et al.
2009-03-05
Polyvalent Protein Complex
App 20080171855 - Rossi; Edmund A. ;   et al.
2008-07-17
Methods And Compositions For Treatment Of Human Immunodeficiency Virus Infection With Conjugated Antibodies Or Antibody Fragments
App 20070264265 - GOLDENBERG; DAVID M. ;   et al.
2007-11-15
Methods and compositions for increasing longevity and protein yield from a cell culture
App 20070092947 - Goldenberg; David M. ;   et al.
2007-04-26
Methods and compositions for generating bioactive assemblies of increased complexity and uses
App 20070086942 - Chang; Chien Hsing ;   et al.
2007-04-19
Methods and compositions for increasing longevity and protein yield from a cell culture
App 20070015250 - Goldenberg; David M. ;   et al.
2007-01-18
Stably tethered structures of defined compositions with multiple functions or binding specificities
App 20060228300 - Chang; Chien Hsing ;   et al.
2006-10-12
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
App 20060228357 - Chang; Chien Hsing ;   et al.
2006-10-12
Methods and compositions for increasing longevity and protein yield from a cell culture
App 20060110793 - Goldenberg; David M. ;   et al.
2006-05-25
Fusion proteins containing recombinant cytotoxic RNAses
App 20060014245 - Goldenberg; David M. ;   et al.
2006-01-19
Folate conjugates and complexes
App 20050261170 - Hansen, Hans J. ;   et al.
2005-11-24
Polyvalent protein complex
App 20050003403 - Rossi, Edmund A. ;   et al.
2005-01-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed